Fundraising Fox
CRISPR
Zug, CH · Founded 2013 · 343 employees on LinkedIn · 11 known investors
Find your way into CRISPR
Sign up to see every warm intro you have to CRISPR
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CRISPR team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.
Founders & leadership
CRISPR was founded in 2013 by Emmanuelle Charpentier.
Investors · 11
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: CLI Ventures's portfolio page · Not right? Tell us
How we know: Khosla Ventures's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: SR One Capital Management's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: Versant Ventures's portfolio page · funding news · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$36M disclosed across 2 of 3 rounds · 2016–2025
- Undisclosed amountPre-Series A roundNov 2025
Spectrum Impact (lead), Vijay Alreja Family Office
Source ↗
▶$1MraisedApr 2020 · 1 investors · Other Health CareRule 506(b)
- Lawrence KleinExecutive Officer
- Rodger NovakExecutive Officer, Director
- Ali BehbahaniDirector
- Samarth KulkarniExecutive Officer, Director
- James KasingerExecutive Officer
- Bradley BolzonDirector
- Tony HoExecutive Officer
- John GreeneDirector
- Katherine HighDirector
- Simeon GeorgeDirector
- Michael TomsicekExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Mar 2020
- Incorporated
- Corporation, Switzerland
- Federal exemptions
- 06b
▶$35MraisedNov 2016 · 1 investors · BiotechnologyRule 506(c)
- Kurt von EmsterDirector
- Sven Ante LundbergExecutive Officer
- Thomas WoiwodeDirector
- Ali BehbahaniDirector
- Rodger NovakExecutive Officer, Director
- Pablo CagnoniDirector
- Bradley BolzonDirector
- N. Anthony ColesDirector
- Kala SubramanianExecutive Officer
- Samarth KulkarniExecutive Officer
- Marc BeckerExecutive Officer
- Simeon J. GeorgeDirector
- Tyler Dylan-HydeExecutive Officer
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Oct 2016
- Incorporated
- Corporation, Switzerland, 2013
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
The CRISPR mafia →6 people who came through CRISPR went on to found or lead other companies.
In the news
Frequently asked questions
- What does CRISPR do?
- CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology. It is led by a management team, board of directors, and scientific founders from the biotech and pharmaceutical industries.
- Who founded CRISPR?
- CRISPR was founded by Emmanuelle Charpentier in 2013.
- Who are CRISPR's investors?
- CRISPR's investors include Avoro Capital Advisors, CLI Ventures, Khosla Ventures, New Enterprise Associates (NEA), SR One Capital Management, Versant Ventures, Wellington Management, Abingworth and 1 more.
- How much funding has CRISPR raised?
- CRISPR has disclosed $36M raised across 2 of its 3 known rounds.
- Where is CRISPR headquartered?
- CRISPR is headquartered in Zug, CH.